A Novel Peptide from <i>Vespa ducalis</i> Induces Apoptosis in Osteosarcoma Cells by Activating the p38 MAPK and JNK Signaling Pathways

DOI Web Site Web Site PubMed 2 Citations 22 References
  • Wu Ren
    Department of Orthopedics, The Second Xiangya Hospital, Central South University
  • Li Ding
    Department of Orthopedics, The Second Xiangya Hospital, Central South University
  • Tang Qi
    Department of Orthopedics, The Second Xiangya Hospital, Central South University
  • Wang Wanchun
    Department of Orthopedics, The Second Xiangya Hospital, Central South University
  • Xie Guangrong
    Department of Psychiatry, The Second Xiangya Hospital, Central South University
  • Dou Pengcheng
    Department of Orthopedics, The Second Xiangya Hospital, Central South University

Bibliographic Information

Other Title
  • A Novel Peptide from Vespa ducalis Induces Apoptosis in Osteosarcoma Cells by Activating the p38 MAPK and JNK Signaling Pathways

Search this article

Abstract

<p>Osteosarcoma (OS) is a typical bone cancer, and most frequently used cancer treatments for OS are limited due to severe drug-related toxicities. Wasp venoms contain functional components that may offer pharmaceutical components for the treatment of cancers. This study aimed to isolate and characterize a novel peptide (venom anti-cancer peptide 1, VACP1) derived from the wasp venom of Vespa ducalis SMITH. Toxins from Vespa ducalis crude venom were separated by gel filtration and purified by C18 reverse-phase HPLC. As examined by Edman degradation, the amino acid sequence of VACP1 is AQKWLKYWKADKVKGFGRKIKKIWFG. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays revealed that VACP1 inhibited the cell proliferation of MG-63, U-2 OS and Saos-2 cells. Furthermore, annexin V and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) staining revealed that VACP1 could induce the apoptosis of OS cell lines. In addition, VACP1 increased the protein levels of cleaved poly ADP-ribose polymerase (PARP), caspase 3, but decreased B-cell lymphoma 2 (Bcl-2). Apoptotic signaling pathway screening in MG-63 cells via an antibody array revealed that VACP1 activated the p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) pathways. The present study demonstrates that VACP1 potently suppressed cell proliferation and induced the cell apoptosis of OS cells by inducing the activation of the p38 MAPK and JNK signaling pathways, suggesting that VACP1 is a promising agent for OS therapy.</p>

Journal

Citations (2)*help

See more

References(22)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top